esc to dismiss

Lung Disease and Sleep Disordered Breathing

  • Increase OSA prevalence in Asthma (2-6x more common in asthma)
    • Less common by HST but likely because you can't actually measure sleep apnea in HST
    • HST underestimates OSA prevalence
  • Prospective data that suggests that asthma was a risk factor for incidence of OSA (39%) 4 years later
  • Relationship with duration of asthma and development of OSA
    • having asthma for >10 years was a/w highest risk for OSA development
    • Therefore asthma in in of it self can develop OSA
    • each 5 year increment of ...
  • Using ICS in a dose dependent fashion was a/w high OSA risk
    • 5 fold increase risk
    • How?
      • ? ICS may lead to genioglossus dysfunction
      • ? ICS may lead to fat deposition to the posterior oropharynx
      • After 4months. increase protrusive strength of the tongue but cannot sustain this (decrease sustain)
        • similar to untreated OSA patients
        • increase in upper airway collapsibility during sleep
        • increase fat accumulaton in the neck by 21% (measured by MRI)
          • no weight gain in these subjects
  • ICS effects
    • structural changesin the tongye (muscle fiber shifts, laminin) and neck (fat) whcih alter the uniform contraction and balanced co-activation of key muscle groups
    • Tongue function and muscle fiber shifts - osa patients
  • Clinical implicaitons
    • predispositon to collapse during sleep and potnetial delteriouss effects on other uaw functions
  • OSA shifts asthma phenotype to more non-eosinophilic
  • Apneas resulting in intrathoraicc pressure swings → mechnical stress on the lower airways
  • Summary Asthma / OSA
    • OSA-2.6x more common in asthma:
    • HSS underestimate OSA prevalence
    • IS use may contribute, apart from other disease-related features
  • OSA influences asthma control:
    • Similar relationships with day- and night-time asthma control
    • CPAP for OSA improves asthma control indices and QoL, but not FEV, (?remodeling)
  • Underlying mechanisms relate to OSA's features:
  • CIH:
    • shifts the inflammation towards less eosinophilic, Th-1 pathways associated with tissue remodeling led to airways obstruction, which may be irreversible
  • Mechanical stress and sleep fragmentation may also contribute
  • OSA prevalence in IPF is high and often unrecognized
  • Symptoms and questionnaires have poor predictive ability in IPF
  • Potential improved survival in IPF with adherent CPAP treatment for OSA
  • OSA is highly common in IPF and largely unrecognized symptoms are not predictive of the diagnosis, thus, formal sleep evaluation should be considered
  • OSA relates with worse IPF outcomes and survival:
    • in part, through a contribution to the RV dysfunction
  • OSA features (hypoxia, pressure swings) could affect various lung compartments (parenchyma, capillary bed), such that the combined effect is worse pulmonary & RV dysfunction, and gas exchange
  • Data are limited and larger/mechanistic studies are needed
  • Addressing OSA early offers a glimpse of hope in a disease with a grim prognosis

Backlinks